France· FR:63274908
EVRENZO 100 mg, comprimé pelliculé
A roxadustat product containing roxadustat, registered in France by ASTELLAS PHARMA EUROPE (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Roxadustat is registered in 13 of 19 countries.
Countries holding a registration under ATC B03XA05 (roxadustat), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Roxadustat · ATC B03XA05
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
Price per daily dose
What a daily dose of roxadustat costs, country by country.
Normalised to the WHO defined daily dose (43 mg), the median price runs from $23.73 in Italy to $77.81 in France — a ×3.3 gap.
- France: $77.81 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Roxadustat · price per daily dose (43 mg)
USD · FX 28 Sept 2026
- FR France$77.81
- IT Italy$23.73
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ROXADUSTAT
- Manufacturer
- ASTELLAS PHARMA EUROPE (PAYS-BAS)
- Country
- France (FR)
- ATC code
- B03XA05
- ATC class
- Roxadustat
- Defined daily dose
- 43 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093023369612 plaquettes PVC aluminium de 1 compriméEUR 158.77
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Roxadustat in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEVRENZOAstellas Pharma Europe B.V., Leiden
- FinlandEvrenzoAstellas Pharma Europe B.V.
- IrelandEvrenzo 100 mg Film-coated tabletAstellas Pharma Europe B.V.
- IcelandEvrenzoAstellas Pharma Europe B.V.
- NetherlandsEvrenzo 100 mg filmomhulde tablettenAstellas Pharma Europe B.V.
- NorwayEvrenzoAstellas Pharma Europe B.V. - Leiden
- PolandEvrenzoAstellas Pharma Europe B.V.
- BelgiumEvrenzo 100 mgAstellas Pharma Europe
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Evrenzo
- Liechtenstein · Evrenzo
- Norway · Evrenzo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/758fbdfa-c98d-4c86-9b61-49480d46bf8f GET /v1/drugs/758fbdfa-c98d-4c86-9b61-49480d46bf8f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63274908",
"date_amm": "2021-08-18",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1574",
"substance": "ROXADUSTAT",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about roxadustat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.